| 孙建然,惠灿灿,邓大同,等.肠道菌群与2型糖尿病及益生菌关系的研究进展[J].安徽医药,2016,20(4):631-634. |
| 肠道菌群与2型糖尿病及益生菌关系的研究进展 |
| The research progress on the relationship between gut microbiota and type 2 diabetes mellitus and probiotics |
| 投稿时间：2016-01-20 |
| DOI： |
| 中文关键词: 肠道菌群 2型糖尿病 益生菌 |
| 英文关键词: gut microbiota type 2 diabetes probiotics |
| 基金项目: |
|
| 摘要点击次数: 2471 |
| 全文下载次数: 312 |
| 中文摘要: |
| 糖尿病等代谢性疾病已经成为威胁人类社会和健康的重要问题之一。2型糖尿病患者肠道菌群与健康人不同,其中肠道菌群在其发生和发展过程中都发挥了巨大的作用。益生菌可以通过改善肠道通透性、增强机体免疫力等多种机制对2型糖尿病起到预防和改善作用。这一新兴的学术领域的飞速发展不但有助于阐明代谢性疾病的发病机制,而且将为探索新的治疗靶点和途径提供方向。 |
| 英文摘要: |
| Metabolic diseases such as diabetes have been the most serious problems for our society. Recent studies show that the structure and function of gut microbiota in patients with type 2 diabetes differ from those in healthy people. Gut microbiota plays an important role in the early onset and deterioration of the diabetes. Probiotic are living organisms, which are helpful in the prevention and alleviation of type 2 diabetes by improving the intestinal permeability, enhancing immunity and other mechanisms. The rapid progress in this emerging field will not only contribute to the elucidation of the pathogenesis of metabolic diseases, but also provide directions for exploring new therapeutic targets and pathways. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
